Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2013 11:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Appoints Richard W. Pascoe as Chief Executive Officer

SAN DIEGO, March 18, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) today announced the appointment of Richard W. Pascoe as...
March 14, 2013 09:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces 2012 Year End Financial Results Conference Call

SAN DIEGO, March 14, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that it will hold a conference call to...
March 14, 2013 08:45 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries

SAN DIEGO, March 14, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) today announced that it intends to cease financing its...
March 13, 2013 16:56 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 25th Annual ROTH Conference

SAN DIEGO, March 13, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that Steve Martin, Interim Chief Executive...
March 07, 2013 08:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at BIO-Europe Spring 2013

SAN DIEGO, March 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that Edward Cox, Vice President Corporate...
February 06, 2013 08:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 15th Annual BIO CEO & Investor Conference

SAN DIEGO, Feb. 6, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that Steve Martin, Interim Chief Executive...
January 03, 2013 07:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Corporate Goals for 2013

SAN DIEGO, Jan. 3, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) today announced its corporate goals for 2013, which includes...
November 21, 2012 06:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences to Present at the 24th Annual Piper Jaffray Healthcare Conference

SAN DIEGO, Nov. 21, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that Steve Martin, Interim Chief Executive...
November 08, 2012 09:00 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences' Executives to Present at Two Upcoming Conferences

SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (www.apricusbio.com) announced today that the Company will present at two upcoming...
November 07, 2012 07:30 ET | Source: Seelos Therapeutics, Inc.

Apricus Biosciences Announces Third Quarter 2012 Financial Results Conference Call

SAN DIEGO, Nov. 7, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) (http://www.apricusbio.com) announced today that it will hold a conference call to...